Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Canellos

Showing results (91-100 of 315) with videos related to

Pageof 32
Sort By:
The New England Journal of Medicine|December 17, 2009
Long-term follow-up of survival in Hodgkin's lymphomaGeorge P Canellos, Donna Niedzwiecki, Jeffrey L Johnson
British Journal of Haematology|July 1, 1977
Basophilic chronic granulocytic leukaemia with hyperhistaminaemiaS Rosenthal, J H Schwartz, G P Canellos
JAMA|October 7, 1983
Treatment and surgical staging of testicular and primary extragonadal germ cell cancerM B Garnick, G P Canellos, J P Richie
The American Journal of Medicine|November 1, 1984
High-dose cytosine arabinoside. Active agent in treatment of non-Hodgkin's lymphomaM A Shipp, R C Takvorian, G P Canellos
Cancer Treatment Reports|July 1, 1982
Phase II trial of combination methyl-GAG and vinblastine in the treatment of metastatic renal adenocarcinomaR F Todd, M B Garnick, G P Canellos
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2004
How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen?George P Canellos, David Duggan, Jeffrey Johnson, et al.
Optometry (St. Louis, Mo.)|March 25, 2005
Multiple calcified deposits along the eyelid margins secondary to chronic renal failure and hyperparathyroidismHarriette Moutopoulos Canellos, Jeffrey Cooper, Anny Paek, et al.
American Journal of Clinical Oncology|October 1, 1986
Relapse with nodular lymphoma following combination chemotherapy for diffuse non-Hodgkin's lymphomaR D Siegel, A T Skarin, G P Canellos
Blood|August 15, 1994
The cellular biology of the Reed-Sternberg cellF G Haluska, A M Brufsky, G P Canellos
Cancer|March 15, 1989
Chlorambucil, vinblastine, procarbazine, and prednisone. An effective but less toxic regimen than MOPP for advanced-stage Hodgkin's diseaseB J Druker, D S Rosenthal, G P Canellos
Pageof 32

Showing results (91-100 of 315) with videos related to

Sort By:
Pageof 32
The New England Journal of Medicine|December 17, 2009
Long-term follow-up of survival in Hodgkin's lymphomaGeorge P Canellos, Donna Niedzwiecki, Jeffrey L Johnson
British Journal of Haematology|July 1, 1977
Basophilic chronic granulocytic leukaemia with hyperhistaminaemiaS Rosenthal, J H Schwartz, G P Canellos
JAMA|October 7, 1983
Treatment and surgical staging of testicular and primary extragonadal germ cell cancerM B Garnick, G P Canellos, J P Richie
The American Journal of Medicine|November 1, 1984
High-dose cytosine arabinoside. Active agent in treatment of non-Hodgkin's lymphomaM A Shipp, R C Takvorian, G P Canellos
Cancer Treatment Reports|July 1, 1982
Phase II trial of combination methyl-GAG and vinblastine in the treatment of metastatic renal adenocarcinomaR F Todd, M B Garnick, G P Canellos
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2004
How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen?George P Canellos, David Duggan, Jeffrey Johnson, et al.
Optometry (St. Louis, Mo.)|March 25, 2005
Multiple calcified deposits along the eyelid margins secondary to chronic renal failure and hyperparathyroidismHarriette Moutopoulos Canellos, Jeffrey Cooper, Anny Paek, et al.
American Journal of Clinical Oncology|October 1, 1986
Relapse with nodular lymphoma following combination chemotherapy for diffuse non-Hodgkin's lymphomaR D Siegel, A T Skarin, G P Canellos
Blood|August 15, 1994
The cellular biology of the Reed-Sternberg cellF G Haluska, A M Brufsky, G P Canellos
Cancer|March 15, 1989
Chlorambucil, vinblastine, procarbazine, and prednisone. An effective but less toxic regimen than MOPP for advanced-stage Hodgkin's diseaseB J Druker, D S Rosenthal, G P Canellos
Pageof 32